CO
Corcept
CORT·NASDAQMenlo Park CAFounded 1998600 employees
Mid CapbiotechPublicEndocrinologyOncology
Platform: Cortisol Mod
Market Cap
$6B
All Drugs
4
Clinical Trials
7
Failed / Terminated
3
FDA Approved
2
Stock Price & Catalysts (CORT)
Loading CORT stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Cevicapivasertib | COR-6696 | Phase 2 | 2 | CFTR | IPF | ||
| Voxamavacamten | COR-770 | Approved | 2 | BET | PNHCeliac | ||
| COR-9456 | COR-9456 | Preclinical | 2 | TIGIT | SLEUC | ||
| COR-9566 | COR-9566 | Approved | 1 | TYK2 | Cervical CaHemophilia A |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)